Difficult decisions ahead over Herceptin breast cancer drug
30th Nov 2005, 22:55 GMT
According to Belgian researchers a drug prescribed for women with advanced breast cancer would be cost-effective for treating some, but not all patients, in the early stages of the disease.
Difficult decisions ahead over Herceptin breast cancer drug related news:
- Herceptin could cost millions — The Cancer Blog
- New breast cancer drug shows promise — The Cancer Blog
- Can healthcare systems afford Herceptin for early breast cancer? — EurekAlert! - Cancer
- Will Herceptin be effective for early breast cancer? — Medical News Today RSS/XML Feed
- Herceptin - can healthcare afford this expensive drug? — News-Medical News Feed
- Breast Cancer Drug Costs 'Could Double' Report Highlights Financial Burden of Using Herceptin — RedOrbit News - Health
- Cancer Drug Green Light — RedOrbit News - Health
- Trusts 'can't afford breast cancer drug' — the Mail online | Health
- Health boards warned to consider costs before offering cancer drug — Scotsman.com News - UK
- Warnings over cost of cancer drug — the Mail online | Health news
Latest news from News-Medical News Feed:
- Children being set up for heart disease later on in life
- New cancer treatments use body's own immune system to kill melanoma tumours
- IVF success compromised by heavy smoking
- Why we all carry on with those bad habits
- Sugar and fizzy drinks linked to pancreatic cancer
- SpectraScience files new patent application
- Global Patient Safety Challenge: Clean Care is Safer Care
- FDA strengthens program for medical devices
- Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer
- More U.S residents trust TV for health info